Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05199> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05199 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05199 label "LX1031 [drugbank:DB05199]" assertion.
- drugbank:DB05199 seeAlso DB05199 assertion.
- drugbank:DB05199 description "LX1031 is an orally-dosed drug candidate for irritable bowel syndrome and other gastrointestinal disorders. LX1031 was generated by Lexicon medicinal chemists, and its target was internally identified as a key control point for the regulation of peripheral serotonin levels. LX1031 is designed to act locally in the gastrointestinal tract by reducing the serotonin available for receptor activation, without affecting serotonin levels in the brain or its central nervous system functions." assertion.
- drugbank:DB05199 identifier "drugbank:DB05199" assertion.
- drugbank:DB05199 title "LX1031" assertion.
- drugbank:DB05199 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05199 drugbank_vocabulary:drugbank-id "DB05199" assertion.
- drugbank:DB05199 bio2rdf_vocabulary:x-identifiers.org DB05199 assertion.
- drugbank:DB05199 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05199" assertion.
- drugbank:DB05199 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05199 bio2rdf_vocabulary:identifier "DB05199" assertion.